See Below
Steven W. Cabble R.Ph., M.S.
Administrative Director, Cancer Institute
Director of Pharmacy
St. Francis Hospital
100 Port Washington Blvd.
Roslyn, N.Y. 11576
(516) 562-6265
From: nyschp.dop-bounce@xxxxxxxxxxxxx [mailto:nyschp.dop-bounce@xxxxxxxxxxxxx] ;
On Behalf Of Tibi-Scherl, Leila
Sent: Monday, June 20, 2016 10:48 AM
To: 'nyschp.dop@xxxxxxxxxxxxx'
Subject: [nyschp.dop] GP2B3A inhibitors & Stress Test Agents
Good morning, all,
A member hospital would like feedback on your practices with GP2B3A inhibitors
and Stress Test Agents. Please respond YES or NO to the following two short
questions:
Is your hospital using to Aggrastat as the primary glycoprotein 2b/3a inhibitor
(as compared to Integrilin)? Yes
Is your hospital using Lexiscan as the primary nuclear stress test agent? Yes
Your time is greatly appreciated. Thank you in advance for taking the time to
respond!
Sincerely,
Leila
--
Leila M. Tibi-Scherl, Pharm.D.
VP, Pharmacy Practice
GNYHA Services, Inc. | 555 W. 57th Street, Suite 1156 | New York, NY 10019
* 212.259.0775 |È646.483.3333 |7 212.541.9032 |*
tibi@xxxxxxxxx<mailto:tibi@xxxxxxxxx>
www.pharmacy.gnyhaservices.com<http://www.pharmacy.gnyhaservices.com/>
PQ Please consider the environment before printing this email.
The information in this e-mail, and any attachments therein, is confidential
and for use by the intended addressee only. If this message is received by you
in error please do not disseminate or read further. Please reply to the sender
that you have received the message in error, then delete the message. Although
Catholic Health Services of Long Island attempts to sweep e-mail and
attachments for viruses, it does not guarantee that either are virus-free and
accepts no liability for any damage sustained as a result of viruses. Thank you.
